Evidence map›Paper›PMID 35392890›Full record

ArticleBMC medical informatics and decision making2022

Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout.

Ritch Te Kampe, Annelies Boonen, Tim L Jansen, Jan Mathis Elling, Marcel Flendrie, Yvonne van Eijk-Hustings, Matthijs Janssen, Caroline van Durme, Hein de Vries

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ritch Te KampeDivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands. r.tekampe@maastrichtuniversity.nl.ORCID 0000-0002-3409-1444
Annelies BoonenDivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0003-0682-9533
Tim L JansenDepartment of Rheumatology, VieCuri Medical Center, Venlo, The Netherlands.ORCID 0000-0003-3026-3154
Jan Mathis EllingCare and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Marcel FlendrieDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.
Yvonne van Eijk-HustingsDepartment of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center, Maastricht, The Netherlands.
Matthijs JanssenDepartment of Rheumatology, VieCuri Medical Center, Venlo, The Netherlands.ORCID 0000-0003-3752-7837
Caroline van DurmeDivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
Hein de VriesCare and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-3640-2517

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study is to develop and assess usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy (ULT) among gout patients in a clinical setting.

methodsThe content of the tool was based on the Integrated Change (I-Change) model. This model combines various socio-cognitive theories and assumes behavioral change is a result of becoming aware of the necessity of change by integrating pre-motivational, motivational, and post-motivational factors. An expert group (five gout experts, three health services researchers, and one health behavior expert) was assembled that decided in three meetings on the tool's specific content (assessments and personalized feedback) using information from preparatory qualitative studies and literature reviews. Usability was tested by a think aloud approach and validated usability questionnaires.

resultsThe I-Change Gout tool contains three consecutive sessions comprising 80 questions, 66 tailored textual feedback messages, and 40 tailored animated videos. Navigation through the sessions was determined by the patients' intention to adapt suboptimal ULT adherence. After the sessions, patients receive an overview of the personalized advices and plans to support ULT adherence. Usability testing among 20 gout patients that (ever) used ULT and seven healthcare professionals revealed an overall score for the tool of 8.4 ± 0.9 and 7.7 ± 1.0 (scale 1-10). Furthermore, participants reported a high intention to use and/or recommend the tool to others. Participants identified some issues for further improvement (e.g. redundant questions, technical issues, and text readability). If relevant, these were subsequently implemented in the I-Change Gout tool, to allow further testing among the following participants.

conclusionThis study provides initial support for the usability by patients and healthcare professionals of the I-Change Gout tool to support ULT adherence behavior.

Indexed as

GoutUric AcidGout SuppressantsHumansInternetMotivationGout SuppressantsUric AcidGoutHealth information systemMedication adherenceProgram evaluationSelf-management

Identifiers

PMID35392890
PMCPMC8991610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.